Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Recurrent Pregnancy Loss Clinical Trials
Recurrent Pregnancy Loss clinical trials are recruiting across 60 cities. Here are the cities with the most active studies:
Recurrent Pregnancy Loss Trial Phases
17 research organizations are sponsoring recurrent pregnancy loss trials.
About Recurrent Pregnancy Loss
Recurrent pregnancy loss is defined as two or more failed pregnancies and affects about 1-2% of couples trying to conceive. Causes include chromosomal abnormalities, uterine anomalies, and immune factors. Treatment depends on the underlying cause and may include hormonal support, surgery, or immunotherapy.
Clinical trials are advancing new treatments for recurrent pregnancy loss. Currently, 21 studies are recruiting a combined 14,289 participants across the United States. Research is being conducted by 17 organizations including Société Internationale d'Urologie, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Ohio State University Comprehensive Cancer Center and 14 others.
2026 Recurrent Pregnancy Loss Research Landscape
As of July 2026, the recurrent pregnancy loss clinical trial landscape includes 21 actively recruiting studies across 60 cities in the United States. These studies are collectively seeking 14,289 participants, with an average enrollment target of 680 per study.
The research spans multiple phases of development: 7 studies are in NA, 5 studies are in PHASE2, 3 studies are in PHASE3, 1 study is in PHASE1. The presence of Phase 3 trials indicates that some recurrent pregnancy loss treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 17 different organizations, including Société Internationale d'Urologie, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Ohio State University Comprehensive Cancer Center, Yale University, Northwestern University, and 12 others. The large number of sponsors reflects significant research interest and investment in recurrent pregnancy loss treatment advancement.
Geographically, recurrent pregnancy loss trials are most concentrated in Los Angeles, California (3 trials); Chicago, Illinois (3 trials); Boston, Massachusetts (3 trials); Minneapolis, Minnesota (3 trials); Ann Arbor, Michigan (3 trials) and 7 other cities.
Featured Recurrent Pregnancy Loss Studies
Highlighted recruiting studies for recurrent pregnancy loss, selected by enrollment size and research scope.
BPH Global Registry
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrel...
Natural History Study of Patients With Excess Androgen
This study will evaluate and gather information in patients with genetic causes of too much androgen (male-like hormone) in order to better understand the effects of too much androgen and describe problems associated with it. Too much androgen in childhood, if untreated, results in rapid growth and early puberty with early cessation of growth and short stature in adulthood. Too much androgen in ad...
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.
Frequently Asked Questions About Recurrent Pregnancy Loss Clinical Trials
Are there recurrent pregnancy loss clinical trials near me?
Yes, there are 21 recurrent pregnancy loss clinical trials currently recruiting across 60+ cities in the United States, including Los Angeles, California; Chicago, Illinois; Boston, Massachusetts. Browse the studies above to find one at a location convenient for you.
How do I join a recurrent pregnancy loss clinical trial?
To join a recurrent pregnancy loss clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are recurrent pregnancy loss clinical trials free?
Yes, participation in recurrent pregnancy loss clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of recurrent pregnancy loss treatments are being studied?
Current recurrent pregnancy loss clinical trials are testing a range of approaches across NA (7 studies), PHASE2 (5 studies), PHASE3 (3 studies), PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 17 research organizations.
Is it safe to participate in recurrent pregnancy loss clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov